跳至主要内容
临床试验/NCT01739543
NCT01739543已完成不适用

A Reduction in C-section Rates Using the Hem-Avert Perianal Stabilizer

Stetrix, Inc.1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2012年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Stetrix, Inc.
入组人数
102
试验地点
1
主要终点
Reduce C-section Rate

研究概览

简要总结

A REDUCTION IN C-SECTION RATES USING THE HEM-AVERT® PERIANAL STABILIZER.

详细描述

This study is being conducted to evaluate an existing FDA approved device called the HEM-AVERT® Perianal Stabilizer for its efficacy in reducing Cesarean births and/or reducing the second stage of labor.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Subject is scheduled for vaginal delivery.
  • •Subject is willing and able to comply with the study plan as indicated by understanding and signing the Subject Informed Consent Form.
  • •Subjects' pre-natal examination indicates that this is to be a single birth delivery.

排除标准

  • •Subject's scheduled for vaginal delivery with anticipated complications.
  • •Subject is unable to understand and sign the informed consent form.
  • •Subject does not deliver at study facility (hospital).

研究组 & 干预措施

Investigational

Experimental

Subject receives Hem-Avert Device.

干预措施: Hem-Avert (Device)

Control

No Intervention

Subject does not receive Hem-Avert Device.

结局指标

主要结局

Reduce C-section Rate

时间窗: 24 hours

The primary objective (purpose) of this study is to evaluate the success rate of the HEM-AVERT® device as a method of reducing C-section rates

次要结局

  • Reduce duration of 2nd stage of labor.(24 hours)

研究者

发起方
Stetrix, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Reduction in C-section Rates Using the Hem-Avert... | 临床试验